Company Filing History:
1 out of 3,539 
1 out of 1,153 
1 out of 2,343 
Years Active: 2016
Title: Joseph Kates: Innovator in Peptide Technology
Introduction
Joseph Kates is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the field of biochemistry, particularly in the development of peptide inhibitors targeting RAS oncoproteins. His innovative work has implications for cancer research and treatment.
Latest Patents
Joseph Kates holds a patent for "Lipopeptide inhibitors of RAS oncoproteins." This invention provides a peptide or peptidomimetic derived from or based upon the amino acid sequence of the C-terminal α-helix or hypervariable region (HVR) of a Ras protein. The patent also includes a nucleic acid encoding the peptide or peptidomimetic, along with methods employing the same. He has 1 patent to his name.
Career Highlights
Throughout his career, Joseph Kates has worked with various organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding of peptide technology and its applications in medicine.
Collaborations
Joseph has collaborated with notable professionals in his field, including Nadya Tarasova and Sergey G Tarasov. These collaborations have enriched his research and contributed to the success of his inventions.
Conclusion
Joseph Kates is a distinguished inventor whose work in peptide technology has the potential to impact cancer treatment significantly. His innovative approach and dedication to research continue to inspire advancements in the field.